Financials
- Market Capitalization 9.05 B
- Employee 315
- Founded 2018
- CEO N/A
- Website www.immunovant.com
- Headquarter Delaware, United States
- FIGI BBG00P5MC0Q8
- Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-8.97
주가매출액비율
—
Related tickers
| # | 이름 | 가격 | 24h % | 7d % | 1M % | 1Y % | 마켓 캡 | 이전 7일 | |
|---|---|---|---|---|---|---|---|---|---|
| 943 | PTGX Protagonist Therapeutics, Inc. - Common Stock | 149.50 USD | -1.32% | -1.36% | +9.20% | +98.99% | 9.67 B USD | ||
| 981 | PCVX Vaxcyte, Inc. - Common Stock | 61.16 USD | +0.11% | -1.12% | +12.22% | +44.59% | 9.10 B USD | ||
| 992 | CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 84.85 USD | +0.01% | +0.18% | +1.14% | +106.45% | 9.00 B USD | ||
| 993 | ABVX Abivax SA - American Depositary Shares | 114.55 USD | +0.22% | -4.34% | -8.29% | +39.70% | 9.00 B USD |